Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...
Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...
Please provide your email address to receive an email when new articles are posted on . GenePOC Inc. has announced the launch and FDA clearance of its Clostridium difficile molecular test, GenePOC ...
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) has just released new guidelines on best practice methods to diagnose Clostridium difficile infection (CDI). The latest ...
Best practices of nucleic acid amplification tests for the diagnosis of clostridioides (clostridium)
A new review looks at the challenges of testing for Clostridioides (Clostridium) difficile infection (CDI) and recommendations for newer diagnostic tests. Accurate diagnosis of CDI is critical for ...
Late last year, The Jewish Hospital-Mercy Health in Cincinnati received a first-place award in a multi-state competition for its efforts to reduce Clostridium difficile infections among inpatients.
Best practices of nucleic acid amplification tests for the diagnosis of clostridioides (clostridium)
Washington, DC - June 3, 2019 - A new review looks at the challenges of testing for Clostridioides (Clostridium) difficile infection (CDI) and recommendations for newer diagnostic tests. Accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback